Fenbendazole, known for treating parasitic infections in animals, has sparked interest in human medicine. Its glucose-blocking mechanism could theoretically impact tumor growth, but scientific validation is limited. Anecdotal evidence highlights its potential, yet the risks of unsupervised use are significant. Professional medical guidance is essential to ensure safety. Clinical trials are needed to confirm its efficacy and explore its potential role in human therapies.